Campaigners have said it is “deeply alarming” that South Africa is reportedly being charged nearly 2.5 times the price paid by most European countries for Oxford-AstraZeneca’s Covid-19 vaccine, claiming such inequality is now a core obstacle to controlling coronavirus.[1] South Africa’s government is struggling to buy vaccines as cases soar in the country. Most vaccines […]